...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Patient Preference and Adherence >New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center
【24h】

New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center

机译：对接受口服卡培他滨治疗的结直肠癌（CRC）门诊患者担心癌症发展/复发（FOP / FCR）的频率和内容的新见解：在综合癌症中心进行的一项初步研究

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: Fear of cancer progression/recurrence (FOP/FCR) is considered one of the most prevalent sources of distress in cancer survivors and associated with lower quality of life and functional impairment. Detailed measures of FOP/FCR are needed because little is known about the knowledge of FOP/FCR, its associations with the patient–doctor relationship, and the rate of adequate therapy. Colorectal cancer (CRC) is one of the most prevalent cancer entities, and oral capecitabine is widely prescribed as treatment. Therefore, we initiated a pilot study to expand the literature on FOP/FCR in CRC outpatients receiving capecitabine and to generate hypotheses for future investigations. Methods: This study included 58 patients treated at a comprehensive cancer center. FOP/FCR was assessed with the Fear of Progression Questionnaire (FOP-Q-SF). Satisfaction with the relationships with doctors was assessed with the Patient–Doctor Relationship Questionnaire-9 (PRDQ-9). Levels of side effects were rated by the patients on a visual analog scale. Clinical data were extracted from the charts. Results: A total of 19 out of 58 patients (36%) suffered from FOP/FCR according to our assessment. Levels of FOP/FCR seemed to be mostly moderate to high. Only four out of the 19 distressed patients (21%) were treated accordingly. Typical side effects of oncological treatment were associated with higher FOP/FCR. Satisfaction with doctor–patient relationships was not associated with FOP/FCR. Regarding single items of FOP/FCR, three out of the five most prevalent fears were associated with close relatives. Discussion: FOP/FCR occurred frequently in more than one in three patients, but was mostly untreated in this sample of consecutive outpatients with CRC receiving oral capecitabine. In detail, most fears were related to family and friends. In addition to an unmet need of patients, our data indicate sources of distress not considered thus far. If replicated in larger studies, results may help to inform intervention development and improve patient care.
机译：背景：对癌症进展/复发的恐惧（FOP / FCR）被认为是癌症幸存者中最普遍的困扰之源之一，并与生活质量和功能受损有关。需要对FOP / FCR进行详细的测量，因为对FOP / FCR的知识，与患者-医生关系的关联以及适当治疗的比率知之甚少。大肠癌（CRC）是最普遍的癌症实体之一，口服卡培他滨被广泛指定为治疗药物。因此，我们启动了一项试点研究，以扩大接受卡培他滨的CRC门诊患者FOP / FCR的文献，并为今后的研究提供假设。方法：本研究包括在综合癌症中心接受治疗的58例患者。 FOP / FCR已通过“对进展的恐惧调查表”（FOP-Q-SF）进行了评估。病人与医生的关系问卷9（PRDQ-9）对与医生的关系的满意度进行了评估。患者以视觉模拟量表对副作用水平进行评估。从图表中提取临床数据。结果：根据我们的评估，在58例患者中，有19例（36％）患有FOP / FCR。 FOP / FCR的水平似乎大体上是中到高。 19名受苦患者中只有4名（21％）得到了相应的治疗。肿瘤治疗的典型副作用与较高的FOP / FCR相关。对医患关系的满意度与FOP / FCR无关。关于FOP / FCR的单个项目，五个最普遍的恐惧中有三个与近亲有关。讨论：FOP / FCR经常发生在超过三分之一的患者中，但是在接受口服卡培他滨治疗的连续性CRC门诊患者中，大多数未接受FOP / FCR治疗。详细地说，大多数恐惧与家人和朋友有关。除了患者的需求未得到满足外，我们的数据还表明到目前为止尚未考虑到的困扰源。如果在较大的研究中重复使用，则结果可能有助于告知干预措施的发展并改善患者护理。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号